Nxera Pharma Co Ltd
(STU:JSS)
€
8.95
-0.15 (-1.65%)
Market Cap: 809.89 Mil
Enterprise Value: 963.00 Mil
PE Ratio: 0
PB Ratio: 2.08
GF Score: 65/100 - Sosei Group Corp R&D Day TranscriptNov 10, 2023
- Q2 2023 Sosei Group Corp Earnings Presentation TranscriptAug 04, 2023
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 23, 2023
- Full Year 2022 Sosei Group Corp Earnings Presentation TranscriptFeb 14, 2023
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Sosei Group Corp R&D Day TranscriptOct 13, 2022
- Q2 2022 Sosei Group Corp Earnings Presentation TranscriptAug 10, 2022
- Full Year 2021 Sosei Group Corp Earnings Presentation TranscriptFeb 10, 2022
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Q2 2021 Sosei Group Corp Earnings Call TranscriptAug 12, 2021€11.7 (-1.68%)Earnings
- Sosei Group Corp at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Full Year 2020 Sosei Group Corp Earnings Call TranscriptFeb 15, 2021€15.4 (+7.69%)Earnings
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Sosei Group Corporation - Special Call TranscriptJan 05, 2021
- Half Year 2020 Sosei Group Corp Earnings Call TranscriptAug 13, 2020€11.1Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 25, 2020
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Sosei Group Corporation - Special Call TranscriptSep 12, 2019
- Q2 2019 Sosei Group Corp Earnings Call TranscriptAug 13, 2019€22.78 (+2.61%)Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 27, 2019
Full Year 2022 Sosei Group Corp Earnings Presentation Transcript
Feb 14, 2023 / 08:00AM GMT
Release Date Price:
€16
(-0.62%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)